APOE2 promotes longevity independent of Alzheimer’s disease is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R21AG052423-01A1
Reverse apoE4 effects by apoE2 expression in Alzheimer's disease
National Institutes of Health
Grant: 3RF1AG057181-01A1S1
Impact of ApoE2 on aging-related conditions
National Institutes of Health
Grant: 3P50AG016574-06S1
Mayo Alzheimers Disease Research Center
National Institutes of Health
Grant: 5R01AG046205-02
ApoE isoform-specific therapy for Alzheimer disease
National Institutes of Health
Grant: 3RF1AG051504-01S1
Integrative translational discovery of vascular risk factors in aging and dementia
National Institutes of Health
Grant: 4P01NS074969-05
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
National Institutes of Health
Grant: 5R01AG035355-11
ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal)
National Institutes of Health
Grant: 5U01AG016976-03
ALZHEIMERS DISEASE DATA COORDINATING CENTER
Fields of Study
Keywords
Sustainable Development Goals